US Patent 7781591 Substituted 3-cyanopyridines as protein kinase inhibitors
Patent 7781591 was granted and assigned to Wyeth on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+67 characters)
Article
Patent abstract
The present teachings provide compounds of formula I
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07781591 Substituted 3-cyanopyridines as protein kinase inhibitors US Patent 7781591 Substituted 3-cyanopyridines as protein kinase inhibitors
Infobox
Patent Number
0778159100
Patent Number
778159100
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077815910
Date of Patent
August 24, 2010
0Patent Application Number
118181190
Date Filed
June 13, 2007
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077815910
Date of Patent
August 24, 2010
0Patent Application Number
118181190
Date Filed
June 13, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07781591 Substituted 3-cyanopyridines as protein kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07781591
Date of patent
August 24, 2010
Patent application number
11818119
Date Filed
June 13, 2007
Patent primary examiner
Find more entities like US Patent 7781591 Substituted 3-cyanopyridines as protein kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
